%0 Consensus Development Conference
%T [National guidelines for the management of patients with chronic lymphocytic leukemia. Sociedad Espan˜ola de Hematologı´a y Hemoterapia and Grupo Espan˜ol de Leucemia Linfocı´tica Cro´ nica].
%A García Marco JA
%A Giraldo Castellano P
%A López Jiménez J
%A Ríos Herranz E
%A Sastre Moral JL
%A Terol Casterá MJ
%A Bosch Albareda F
%A  
%A  
%J Med Clin (Barc)
%V 141
%N 4
%D Aug 2013 17
%M 23830547
%F 3.2
%R 10.1016/j.medcli.2013.04.041
%X Chronic lymphocytic leukemia is the most common chronic lymphoproliferative disorder in Spain. The clinical management of this entity varies widely. Currently, in Spain, there are no national consensus guidelines, such as those published in other countries, to guide the diagnosis and treatment of this malignancy and the use of prognostic scores. This article reviews the current scientific literature and addresses issues on the diagnosis of chronic lymphocytic leukemia, the spread of the disease, the presence of comorbidities, the classification of prognostic scores, the common treatment regimens stratified by risk factors, and the management of complications associated with both the disease and its treatment, as well as the various controversies related to this entity. This document was drafted with the collaboration of national experts and aims to establish practical guidelines with their corresponding levels of evidence and grades of recommendation to guide the diagnosis, treatment and follow-up of patients with chronic lymphocytic leukemia.